In 2024, PASO Medical launched a significant collaboration with the Hudson Institute of Medical Research to support cutting-edge lung cancer research through the creation of the PASO Fellowship, awarded to Associate Professor Daniel Gough.

A/Prof Gough leads Hudson’s Signal Transduction in Cancer Biology Research group, which investigates how immune signalling pathways influence the development and progression of lung cancer. His team’s work is focused on uncovering new therapeutic strategies that could significantly improve outcomes for patients.

The PASO Fellowship provides sustained support for this research, allowing A/Prof Gough and his team—including postdoctoral fellows, PhD students, and bioinformatics specialists—to focus on discovery science and translational research that bridges laboratory findings with clinical applications.

“This fellowship means that my team and I can spend more time in the lab discovering and testing potential cures and less time applying for scarce funding,” said A/Prof Gough.

PASO Medical’s Medical Director and Founder, A/Prof Vinod Ganju, shared:

“Our partnership with Hudson Institute reflects PASO’s deep commitment to advancing cancer research. By supporting this work, we’re helping to build the foundations for better therapies and improved outcomes for lung cancer patients.”

The PASO Fellowship is a key part of our ongoing mission to support innovation and excellence in cancer care.